Market Cap 38.63B
Revenue (ttm) 14.55B
Net Income (ttm) 2.20B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 15.59
Profit Margin 15.11%
Debt to Equity Ratio 0.52
Volume 9,519,500
Avg Vol 8,179,568
Day's Range N/A - N/A
Shares Out 4.43B
Stochastic %K 42%
Beta 0.13
Analysts Sell
Price Target $11.89

Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides var...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 44 1932 959 500
Address:
The Heights, Building 5, First Floor, Weybridge, United Kingdom
CapitalInsight
CapitalInsight May. 29 at 10:57 AM
HALEOS LABS – Q4 RESULTS ⚠️ Q4 Consolidated Net Profit declines sharply to ₹0.4 Cr vs ₹3 Cr YoY 📉 ⚠️ Q4 Revenue falls to ₹75.1 Cr vs ₹89.1 Cr YoY ⚠️ Q4 EBITDA declines to ₹4.2 Cr vs ₹7.4 Cr YoY ⚠️ EBITDA Margin moderates to 5.55% vs 8.32% YoY 📊 Weak operational performance and margin pressure impacted overall profitability during the quarter. $HLN
0 · Reply
BillionerOfKing
BillionerOfKing May. 25 at 11:17 PM
$HLN Current Stock Price: $9.31 Contracts to trade: $10.0 HLN Jun 18 2026 Call Entry: $0.05 Exit: $0.06 ROI: 39% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
CapitalMonk
CapitalMonk May. 20 at 7:51 AM
$HLN Price: $9.20 (+0.33%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.63% RSI: 46.6 | Momentum: Moderate Volume: -29.2% vs avg Volatility: 1.32% Support: $8.89 | Resistance: $9.66 Sourch: http://marketbaubles.com/
0 · Reply
CapitalMonk
CapitalMonk May. 4 at 2:54 PM
$HLN Price: $9.31 (-0.69%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.19% RSI: 36.5 | Momentum: Moderate Volume: -87.9% vs avg Volatility: 1.09% Support: $9.07 | Resistance: $9.95 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
CapitalMonk
CapitalMonk Apr. 8 at 2:26 PM
$HLN Price: $10.00 (+1.21%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.84% RSI: 36.8 | Momentum: Moderate Volume: -79.0% vs avg Volatility: 1.59% Support: $9.65 | Resistance: $10.64 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Bazzzigar
Bazzzigar Mar. 10 at 10:40 PM
$HLN HIMS
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 25 at 10:39 PM
$HLN exhibits 1W trend strength as major stake sales clear. 1D RSI is resetting while 4H STOCH shows a bullish crossover. 30M CCI confirms buyer interest making this a classic consolidation play for a breakout. @DailyAnalysis
0 · Reply
stalkerjude
stalkerjude Feb. 20 at 4:15 PM
$HLN Haleon operates consumer healthcare brands. Cash flows are stable with modest growth. Pricing power supports margins.
0 · Reply
mohamettarik
mohamettarik Feb. 18 at 10:42 AM
$HLN lesson number 1 , dont buy on top....
0 · Reply
CoachHendo
CoachHendo Feb. 18 at 9:27 AM
$HLN ohh what a gap to fill! LT!
0 · Reply
Latest News on HLN
Haleon Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:00 AM EDT - 5 weeks ago

Haleon Earnings Call Transcript: Q1 2026


Haleon Earnings release: Q1 2026

Apr 29, 2026, 4:00 AM EDT - 5 weeks ago

Haleon Earnings release: Q1 2026


Haleon Slides: Q1 2026

Apr 29, 2026, 4:00 AM EDT - 5 weeks ago

Haleon Slides: Q1 2026


Haleon launches ‘For the Assist’ campaign

2026-04-28T11:32:33.000Z - 5 weeks ago

Haleon launches ‘For the Assist’ campaign


Haleon appoints Richard Manso as U.S. CMO

2026-04-27T14:32:33.000Z - 5 weeks ago

Haleon appoints Richard Manso as U.S. CMO


Haleon price target raised to 512 GBp from 510 GBp at Berenberg

2026-03-17T17:41:56.000Z - 2 months ago

Haleon price target raised to 512 GBp from 510 GBp at Berenberg


Haleon Earnings Call Transcript: H2 2025

Feb 25, 2026, 3:45 AM EST - 3 months ago

Haleon Earnings Call Transcript: H2 2025


Haleon Annual report: H2 2025

Feb 25, 2026, 3:45 AM EST - 3 months ago

Haleon Annual report: H2 2025


Haleon Annual report: H2 2025

Feb 25, 2026, 3:45 AM EST - 3 months ago

Haleon Annual report: H2 2025


Haleon Slides: H2 2025

Feb 25, 2026, 3:45 AM EST - 3 months ago

Haleon Slides: H2 2025


Haleon Earnings Call Transcript: H2 2025

Feb 25, 2026, 2:00 AM EST - 3 months ago

Haleon Earnings Call Transcript: H2 2025


Haleon Annual report: H2 2025

Feb 25, 2026, 2:00 AM EST - 3 months ago

Haleon Annual report: H2 2025


Haleon Annual report: H2 2025

Feb 25, 2026, 2:00 AM EST - 3 months ago

Haleon Annual report: H2 2025


Haleon Slides: H2 2025

Feb 25, 2026, 2:00 AM EST - 3 months ago

Haleon Slides: H2 2025


Haleon upgraded to Overweight from Equal Weight at Barclays

2026-01-23T09:40:44.000Z - 4 months ago

Haleon upgraded to Overweight from Equal Weight at Barclays


Haleon upgraded to Buy from Hold at HSBC

2026-01-21T10:05:21.000Z - 4 months ago

Haleon upgraded to Buy from Hold at HSBC


Haleon price target raised to 450 GBp from 440 GBp at Jefferies

2026-01-20T11:45:49.000Z - 4 months ago

Haleon price target raised to 450 GBp from 440 GBp at Jefferies


Haleon downgraded to Sell from Hold at Deutsche Bank

2026-01-12T10:45:29.000Z - 5 months ago

Haleon downgraded to Sell from Hold at Deutsche Bank


Haleon added to European Conviction List at Goldman Sachs

2026-01-05T09:25:06.000Z - 5 months ago

Haleon added to European Conviction List at Goldman Sachs


Haleon price target raised to 517 GBp from 507 GBp at Berenberg

2025-11-07T19:10:36.000Z - 7 months ago

Haleon price target raised to 517 GBp from 507 GBp at Berenberg


Haleon Earnings Call Transcript: Q3 2025

Oct 30, 2025, 5:00 AM EDT - 7 months ago

Haleon Earnings Call Transcript: Q3 2025


Haleon Earnings release: Q3 2025

Oct 30, 2025, 5:00 AM EDT - 7 months ago

Haleon Earnings release: Q3 2025


Haleon Slides: Q3 2025

Oct 30, 2025, 5:00 AM EDT - 7 months ago

Haleon Slides: Q3 2025


Haleon price target raised to 507 GBp from 500 GBp at Berenberg

2025-10-10T16:30:29.000Z - 8 months ago

Haleon price target raised to 507 GBp from 500 GBp at Berenberg


Haleon downgraded to Equal Weight from Overweight at Barclays

2025-09-16T09:15:13.000Z - 9 months ago

Haleon downgraded to Equal Weight from Overweight at Barclays


Haleon upgraded to Buy from Neutral at Goldman Sachs

2025-09-10T08:30:19.000Z - 9 months ago

Haleon upgraded to Buy from Neutral at Goldman Sachs


Haleon price target lowered to 500 GBp from 503 GBp at Berenberg

2025-08-12T16:35:40.000Z - 10 months ago

Haleon price target lowered to 500 GBp from 503 GBp at Berenberg


Haleon CEO: 'Quite optimistic about emerging market growth'

Jul 31, 2025, 4:53 AM EDT - 11 months ago

Haleon CEO: 'Quite optimistic about emerging market growth'


Haleon Earnings Call Transcript: H1 2025

Jul 31, 2025, 4:30 AM EDT - 11 months ago

Haleon Earnings Call Transcript: H1 2025


Haleon Quarterly report: H1 2025

Jul 31, 2025, 4:30 AM EDT - 11 months ago

Haleon Quarterly report: H1 2025


Haleon Slides: H1 2025

Jul 31, 2025, 4:30 AM EDT - 11 months ago

Haleon Slides: H1 2025


UK's Haleon cuts annual organic revenue growth forecast

Jul 31, 2025, 2:26 AM EDT - 11 months ago

UK's Haleon cuts annual organic revenue growth forecast


Haleon price target lowered to 450 GBp from 475 GBp at Barclays

2025-07-08T17:30:47.000Z - 11 months ago

Haleon price target lowered to 450 GBp from 475 GBp at Barclays

HLN


HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER

Jun 24, 2025, 8:00 AM EDT - 1 year ago

HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER


Haleon Transcript: CMD 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Haleon Transcript: CMD 2025


Haleon Slides: FY 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Haleon Slides: FY 2025


Haleon Earnings Call Transcript: Q1 2025

Apr 30, 2025, 3:30 AM EDT - 1 year ago

Haleon Earnings Call Transcript: Q1 2025


Haleon Earnings release: Q1 2025

Apr 30, 2025, 3:30 AM EDT - 1 year ago

Haleon Earnings release: Q1 2025


Haleon Slides: Q1 2025

Apr 30, 2025, 3:30 AM EDT - 1 year ago

Haleon Slides: Q1 2025


Pfizer sells entire Haleon stake for $3.24 billion

Mar 19, 2025, 3:26 AM EDT - 1 year ago

Pfizer sells entire Haleon stake for $3.24 billion

PFE


Pfizer to dispose of entire Haleon stake

Mar 18, 2025, 12:54 PM EDT - 1 year ago

Pfizer to dispose of entire Haleon stake

PFE


Haleon CEO: We're relatively low-exposed to tariffs

Feb 27, 2025, 10:30 AM EST - 1 year ago

Haleon CEO: We're relatively low-exposed to tariffs


Haleon Earnings Call Transcript: H2 2024

Feb 27, 2025, 4:00 AM EST - 1 year ago

Haleon Earnings Call Transcript: H2 2024


Haleon Annual report: H2 2024

Feb 27, 2025, 4:00 AM EST - 1 year ago

Haleon Annual report: H2 2024


Haleon Annual report: H2 2024

Feb 27, 2025, 4:00 AM EST - 1 year ago

Haleon Annual report: H2 2024


Haleon Slides: H2 2024

Feb 27, 2025, 4:00 AM EST - 1 year ago

Haleon Slides: H2 2024


Haleon Earnings Call Transcript: H2 2024

Feb 26, 2025, 7:00 PM EST - 1 year ago

Haleon Earnings Call Transcript: H2 2024


Haleon Annual report: H2 2024

Feb 26, 2025, 7:00 PM EST - 1 year ago

Haleon Annual report: H2 2024


Haleon Annual report: H2 2024

Feb 26, 2025, 7:00 PM EST - 1 year ago

Haleon Annual report: H2 2024


Haleon Slides: H2 2024

Feb 26, 2025, 7:00 PM EST - 1 year ago

Haleon Slides: H2 2024


Pfizer Sells 700 Million Haleon Shares for $3 Billion

Jan 15, 2025, 2:57 AM EST - 1 year ago

Pfizer Sells 700 Million Haleon Shares for $3 Billion

PFE


Haleon Pakistan to manufacture Centrum multivitamins

Dec 12, 2024, 4:31 AM EST - 1 year ago

Haleon Pakistan to manufacture Centrum multivitamins


Haleon Earnings Call Transcript: Q3 2024

Oct 31, 2024, 5:00 AM EDT - 1 year ago

Haleon Earnings Call Transcript: Q3 2024


Haleon Earnings release: Q3 2024

Oct 31, 2024, 5:00 AM EDT - 1 year ago

Haleon Earnings release: Q3 2024


Haleon Slides: Q3 2024

Oct 31, 2024, 5:00 AM EDT - 1 year ago

Haleon Slides: Q3 2024


Haleon reports marginal decline in third-quarter revenue

Oct 31, 2024, 3:21 AM EDT - 1 year ago

Haleon reports marginal decline in third-quarter revenue


Is the Haleon share price in trouble ahead of earnings?

Oct 30, 2024, 4:02 AM EDT - 1 year ago

Is the Haleon share price in trouble ahead of earnings?


Haleon Transcript: Fireside Chat

Oct 14, 2024, 8:00 PM EDT - 1 year ago

Haleon Transcript: Fireside Chat


Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon

Oct 1, 2024, 2:13 AM EDT - 1 year ago

Pfizer offloads $3.3 bln stake in Sensodyne-maker Haleon

PFE


Sensodyne maker Haleon to raise stake in China JV

Sep 27, 2024, 5:11 AM EDT - 1 year ago

Sensodyne maker Haleon to raise stake in China JV


Haleon Earnings Call Transcript: H1 2024

Aug 1, 2024, 4:00 AM EDT - 2 years ago

Haleon Earnings Call Transcript: H1 2024


Haleon Quarterly report: H1 2024

Aug 1, 2024, 4:00 AM EDT - 2 years ago

Haleon Quarterly report: H1 2024


Haleon Slides: H1 2024

Aug 1, 2024, 4:00 AM EDT - 2 years ago

Haleon Slides: H1 2024


Haleon Earnings Call Transcript: H1 2024

Jul 31, 2024, 8:00 PM EDT - 2 years ago

Haleon Earnings Call Transcript: H1 2024


Haleon Quarterly report: H1 2024

Jul 31, 2024, 8:00 PM EDT - 2 years ago

Haleon Quarterly report: H1 2024


Haleon Slides: H1 2024

Jul 31, 2024, 8:00 PM EDT - 2 years ago

Haleon Slides: H1 2024


Haleon Slides: FY 2024

Jun 5, 2024, 10:30 AM EDT - 2 years ago

Haleon Slides: FY 2024


GSK intends to sell its remaining stake in Haleon

May 16, 2024, 12:33 PM EDT - 2 years ago

GSK intends to sell its remaining stake in Haleon

GSK


Haleon Earnings Call Transcript: Q1 2024

May 1, 2024, 4:00 AM EDT - 2 years ago

Haleon Earnings Call Transcript: Q1 2024


Haleon Earnings release: Q1 2024

May 1, 2024, 4:00 AM EDT - 2 years ago

Haleon Earnings release: Q1 2024


Haleon Slides: Q1 2024

May 1, 2024, 4:00 AM EDT - 2 years ago

Haleon Slides: Q1 2024


Haleon's first-quarter revenue misses expectations

May 1, 2024, 3:00 AM EDT - 2 years ago

Haleon's first-quarter revenue misses expectations


CapitalInsight
CapitalInsight May. 29 at 10:57 AM
HALEOS LABS – Q4 RESULTS ⚠️ Q4 Consolidated Net Profit declines sharply to ₹0.4 Cr vs ₹3 Cr YoY 📉 ⚠️ Q4 Revenue falls to ₹75.1 Cr vs ₹89.1 Cr YoY ⚠️ Q4 EBITDA declines to ₹4.2 Cr vs ₹7.4 Cr YoY ⚠️ EBITDA Margin moderates to 5.55% vs 8.32% YoY 📊 Weak operational performance and margin pressure impacted overall profitability during the quarter. $HLN
0 · Reply
BillionerOfKing
BillionerOfKing May. 25 at 11:17 PM
$HLN Current Stock Price: $9.31 Contracts to trade: $10.0 HLN Jun 18 2026 Call Entry: $0.05 Exit: $0.06 ROI: 39% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
CapitalMonk
CapitalMonk May. 20 at 7:51 AM
$HLN Price: $9.20 (+0.33%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.63% RSI: 46.6 | Momentum: Moderate Volume: -29.2% vs avg Volatility: 1.32% Support: $8.89 | Resistance: $9.66 Sourch: http://marketbaubles.com/
0 · Reply
CapitalMonk
CapitalMonk May. 4 at 2:54 PM
$HLN Price: $9.31 (-0.69%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.19% RSI: 36.5 | Momentum: Moderate Volume: -87.9% vs avg Volatility: 1.09% Support: $9.07 | Resistance: $9.95 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
CapitalMonk
CapitalMonk Apr. 8 at 2:26 PM
$HLN Price: $10.00 (+1.21%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.84% RSI: 36.8 | Momentum: Moderate Volume: -79.0% vs avg Volatility: 1.59% Support: $9.65 | Resistance: $10.64 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Bazzzigar
Bazzzigar Mar. 10 at 10:40 PM
$HLN HIMS
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 25 at 10:39 PM
$HLN exhibits 1W trend strength as major stake sales clear. 1D RSI is resetting while 4H STOCH shows a bullish crossover. 30M CCI confirms buyer interest making this a classic consolidation play for a breakout. @DailyAnalysis
0 · Reply
stalkerjude
stalkerjude Feb. 20 at 4:15 PM
$HLN Haleon operates consumer healthcare brands. Cash flows are stable with modest growth. Pricing power supports margins.
0 · Reply
mohamettarik
mohamettarik Feb. 18 at 10:42 AM
$HLN lesson number 1 , dont buy on top....
0 · Reply
CoachHendo
CoachHendo Feb. 18 at 9:27 AM
$HLN ohh what a gap to fill! LT!
0 · Reply
ivyjCampb03
ivyjCampb03 Jan. 25 at 5:17 PM
$HLN Defensive structure holding support. Trend stabilizing. Needs breakout.
0 · Reply
CleanSheetCap
CleanSheetCap Dec. 25 at 4:56 AM
$HLN Structural upside remains conditional on management’s ability to convert scale into defensible margin expansion, with outcomes shaped by timing and discipline. Evidence of traction would justify structural re‑rating.
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:33 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:33 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:33 PM
0 · Reply
TonySuprano
TonySuprano Dec. 16 at 8:30 PM
0 · Reply